Micromet (MITI) Annouces Phase I Publication of Blinatumomab for NHL
Tweet Send to a Friend
Micromet, Inc. (NASDAQ: MITI) today announced the publication of a poster with new data from its ongoing phase 1 clinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
